This month we feature our partners at HalioDx. HalioDx (https://www.haliodx.com/) is the pioneer of immuno-oncology diagnostic, a transforming approach of cancer care that benefits from novel and deep understanding of the tumour immune microenvironment. The company provides a unique and [...]
An independent review entitled “Immunoscore®: A Diagnostic Assay for Clinical Management of Colon Cancer” is published on March 30th, 2020 in Molecular Diagnosis and Therapy (Blair, H.A. Mol Diagn Ther (2020) a specialized journal of Springer Nature group that provides researchers and [...]
Cancer Trials Ireland was established in 1996 under the name of Irish Cooperative Oncology Research Group (ICORG). A group of cancer consultants had the aim to create more opportunities for patients to access cutting edge treatments by putting a formal [...]
Hear ye! Hear ye! The Spring 2020 COLOSSUS newsletter is out now! Read the latest update on the COLOSSUS translational study from partners at Cancer Trials Ireland, a spotlight feature on our partner HalioDx, the dissemination round-up and much more!
Principal Investigators (PIs) involved in the COLOSSUS and MoTriColor projects hosted a packed public meeting for people with colorectal cancer, their carers, and relatives on February 27, 2020, at the Vall d´Hebron Institute of Oncology in Barcelona. Berta Colldeforns Riera [...]
Our partners VIB, a non-profit life sciences research institute in Belgium, is pleased to announce the first Tumor Heterogeneity, Plasticity and Therapy meeting which will be held on May 14-15, 2020 in the historical city of Leuven, Belgium. The upcoming deadlines [...]
Third Party Embeds
Necessary cookies help make a website usable by enabling basic functions. The website cannot function properly without these cookies. You may disable these by changing your browser settings but this will affect how the website functions.